Global Shigella Nucleic Acid Test Kit Market Size By Type (Dry PCR, Fluorescence PCR), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Shigella Nucleic Acid Test Kit Market was valued at USD 540 million in 2023 and is expected to surpass USD 987 million by 2031, growing at a CAGR of 7.8% during the forecast period from 2023 to 2031. The growth is driven by the increasing incidence of shigellosis globally, especially in developing regions with limited sanitation infrastructure, and the need for rapid, accurate diagnostic tools. Shigella nucleic acid test kits offer higher sensitivity and specificity compared to traditional culture-based methods, making them essential in outbreak response, routine clinical diagnosis, and public health surveillance.

Drivers:

Rising Global Incidence of Shigellosis:

The increasing prevalence of shigellosis, especially in children under five and in regions with poor hygiene conditions, is driving demand for accurate diagnostic kits. These tests are essential for early detection and control of outbreaks.

Advancements in Molecular Diagnostics:

Technological developments such as multiplex PCR, real-time RT-PCR, and isothermal amplification methods have improved the speed, sensitivity, and specificity of Shigella nucleic acid detection, expanding their clinical utility.

Supportive Government and NGO Initiatives:

Public health agencies and international organizations are funding programs to enhance diagnostic capabilities in low-resource settings, boosting the adoption of nucleic acid test kits.

Restraints:

High Cost of Molecular Test Kits:

Compared to traditional diagnostic techniques, nucleic acid-based test kits are more expensive, limiting widespread use in cost-sensitive and resource-limited areas.

Need for Skilled Personnel and Lab Infrastructure:

These diagnostic methods often require trained technicians and sophisticated laboratory infrastructure, which can be lacking in rural or underdeveloped regions.

Opportunity:

Integration with Point-of-Care Testing Platforms:

The emergence of compact, user-friendly, and portable molecular diagnostic platforms represents a significant opportunity to expand access to Shigella testing in field settings, refugee camps, and remote healthcare centers.

Market Penetration in Emerging Economies:

Expanding awareness and healthcare infrastructure in Asia-Pacific, Africa, and Latin America provides significant growth potential for diagnostic kit manufacturers targeting Shigella control.

Market by System Type Insights:

By system type, the RT-PCR-based Shigella test kits dominated the market in 2023. Their high accuracy and growing integration into centralized and decentralized healthcare systems have driven widespread adoption. The isothermal amplification-based kits, particularly those based on LAMP and RPA technologies, are expected to witness the fastest growth due to their suitability for low-resource settings and faster turnaround times.

Market by End-use Insights:

Hospitals and Clinical Laboratories accounted for the largest share in 2023, primarily due to the demand for precise diagnostics in managing enteric infections. However, the Public Health Surveillance segment is projected to grow rapidly during the forecast period, driven by international efforts to track and curb infectious disease outbreaks, especially in developing nations.

Market by Regional Insights:

Asia-Pacific emerged as the leading region in 2023, supported by a high burden of shigellosis, increasing healthcare investments, and the rollout of government-supported diagnostic programs in countries like India, Bangladesh, and Indonesia. Africa and Latin America are poised for significant growth, given rising awareness, increased public health funding, and partnerships with NGOs for infectious disease management. North America and Europe maintain steady demand due to their strong diagnostic infrastructure and emphasis on early detection.

Competitive Scenario:

Key players in the Global Shigella Nucleic Acid Test Kit Market include Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, Qiagen N.V., Meridian Bioscience, Becton Dickinson and Company, QuidelOrtho Corporation, Luminex Corporation, Molbio Diagnostics, and Cepheid. These companies are focusing on strategic collaborations, R&D investments, and regional expansions. Notable developments include:

In 2024, Bio-Rad introduced a multiplex real-time PCR kit specifically optimized for enteric pathogens, including Shigella spp., enhancing diagnostic throughput in clinical labs.

In 2023, Qiagen expanded its syndromic testing portfolio with CE-IVD marked Shigella detection assays targeting pediatric diarrhea.

Thermo Fisher Scientific, in partnership with a global NGO, launched a field-deployable Shigella test kit with LAMP technology aimed at refugee healthcare settings in Africa.

Scope of Work – Global Shigella Nucleic Acid Test Kit Market

Report Metric Details

Market Size (2023) USD 540 million

Projected Market Size (2031) USD 987 million

CAGR (2023–2031) 7.8%

Market Segments System Type (RT-PCR, LAMP, RPA), End-Use (Hospitals, Public Health, Clinics)

Growth Drivers Rising incidence of shigellosis, advances in molecular diagnostics, NGO and government healthcare programs

Opportunities Point-of-care integration, expansion into emerging markets

Key Market Developments:

2023: Qiagen introduced a CE-approved rapid Shigella nucleic acid test as part of its syndromic diagnostic panel.

2024: Molbio Diagnostics launched a cartridge-based Shigella LAMP test for real-time deployment in India’s rural public health system.

2025: Abbott Laboratories announced a strategic partnership with GAVI for deploying low-cost nucleic acid kits across Sub-Saharan Africa.

FAQs:

1) What is the current market size of the Global Shigella Nucleic Acid Test Kit Market?

The market was valued at USD 540 million in 2023.

2) What is the major growth driver of the Global Shigella Nucleic Acid Test Kit Market?

The key driver is the rising global incidence of shigellosis and the need for rapid, accurate diagnostics.

3) Which is the largest region during the forecast period in the Global Shigella Nucleic Acid Test Kit Market?

Asia-Pacific is the leading region, driven by a high disease burden and expanding healthcare infrastructure.

4) Which segment accounted for the largest market share in the Global Shigella Nucleic Acid Test Kit Market?

The RT-PCR-based test kits segment held the largest market share in 2023.

5) Who are the key market players in the Global Shigella Nucleic Acid Test Kit Market?

Key players include Bio-Rad, Qiagen, Thermo Fisher Scientific, Abbott Laboratories, and Molbio Diagnostics.

Would you like a visual infographic to accompany this report summary?